Health Care Equipment

Mindray

Mindray released FY2026 Q1 earnings on April 28 During-Market (BJT), actual revenue CNY 8.352 B (forecast CNY 8.382 B), actual EPS CNY 1.9224 (forecast CNY 1.7195)

Mindray to release FY2026 Q1 earnings report on April 29 During-Market BJT, forecast revenue CNY 8.382 B, EPS CNY 1.7242

Mindray released FY2025 Annual Earnings on March 30 After-Market (BJT), Actual Revenue CNY 33.28 B (Forecast CNY 34.21 B), Actual EPS CNY 6.7145 (Forecast CNY 7.9194)

Mindray released FY2025 Q4 earnings on March 30 After-Market (BJT), actual revenue CNY 7.448 B (forecast CNY 7.589 B), actual EPS CNY 0.4668 (forecast CNY 0.9417)

Mindray to Release FY2025 Earnings on March 31 After-Market (BJT), Forecast Revenue CNY 34.21 B, EPS CNY 7.9194

Mindray released FY2025 9 Months earnings on October 29 After-Market (BJT), actual revenue CNY 25.83 B, actual EPS CNY 6.2479

Mindray released FY2025 Q3 earnings on October 29 After-Market (BJT), actual revenue CNY 9.091 B (forecast CNY 9.532 B), actual EPS CNY 2.064 (forecast CNY 2.462)

Mindray to Release FY2025 Q3 Earnings on October 30 After-Market (BJT), Forecast Revenue CNY 9.532 B, EPS CNY 2.462

Mindray released FY2025 Semi-Annual Earnings on August 27 During-Market BJT, actual revenue CNY 16.74 B (forecast CNY 17.73 B), actual EPS CNY 4.1839

Mindray released FY2025 Q2 earnings on August 27 During-Market (BJT), actual revenue CNY 8.506 B (forecast CNY 10.47 B), actual EPS CNY 2.0141 (forecast CNY 2.5754)

Mindray to Release FY2025 Semi-Annual Earnings on August 29, 2025 (BJT), Forecast Revenue CNY 17.73 B

Mindray Medical Obtains New Design Patent for Ultrasound Diagnostic Device

Mindray Medical Obtains New Patent Authorization

Mindray's Secretary Answers Investor Questions on Ultrasound Products

Mindray Medical Obtains a New Patent Authorization

Mindray Addresses Investor Concerns Over Market Value and Impact of Procurement Policies

Mindray Medical Had a Block Trade

Mindray Medical Submits New Trademark Application and Increases R&D Investment

Mindray Medical Receives AAA ESG Rating

Mindray Medical Receives Patent Authorization for Ultrasonic Device Extension Cup Kit

159883

159898

300760

GEHC

562600

Foreign medical device companies are enhancing their strategies in China, focusing on localized R&D and production. Canon Medical Systems has achieved local manufacturing of various medical products and aims to produce key components domestically. The company emphasizes collaboration with Chinese clinicians to meet local demands. Siemens Healthineers and GE Healthcare also showcased their local innovations at the China International Medical Equipment Fair, with a significant portion of their products developed and manufactured in China. This shift aims to address the growing clinical needs in the Chinese market.

Yicai

Siemens Healthineers AG

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

iShares US Medical Devices

GE HealthCare Tech

SPDR S&P Health Equip

ChinaAMC CSI All Share Health Care Devices ETF

Global Medical Device Giants Upgrade China Strategies to Advance Local R&D, Production

002487

002531

In the first quarter of 2026, over 1300 A-share listed companies were surveyed by institutions. Companies such as DHI, Mindray, and Titan Wind attracted significant attention, with over 300 institutions visiting. Some of the surveyed companies saw their stock prices double, demonstrating outstanding performance

Wallstreetcn

Titan Wind

Over 1300 Companies Surveyed in Q1, Four Major Sectors Highly Favored

Mindray's 2025 revenue reached 33.282 billion yuan, a year-on-year decrease of 9.38%, with net profit at 8.136 billion yuan, down 30.28%. Domestic policy pressures leading to reduced hospital procurement budgets were the main cause. International revenue surpassed domestic for the first time, with its share rising to 53%, and Europe saw a sharp 17% increase. Emerging businesses such as minimally invasive surgery grew by 38.85%. Management expects domestic operations to return to positive growth in 2026

Mindray's 2025 Revenue Decreased 9.4% Year-on-Year, Net Profit Down 30.3%, Emerging Businesses Grew 30% | Earnings Insights

512170

The global diagnostic imaging equipment market is projected to exceed USD 80 billion by 2034, driven by rising chronic disease incidences and an aging population. Key factors include technological advancements, increased healthcare expenditure, and a growing preference for early diagnosis. North America currently leads the market, supported by robust healthcare infrastructure and high spending. Europe and Asia-Pacific are also experiencing significant growth due to similar trends. Major companies in the sector include Siemens Healthineers, GE Healthcare, and Philips Healthcare, among others.

prnewswire

Hwabao WP CSI Medical Service ETF

Koninklijke Philips Elect

10:16 ETGlobal Diagnostic Imaging Equipment Market is Projected to Cross USD 80 Billion by 2034 Due to the Rising Demand for Advanced Imaging Technologies | DelveInsight

The American financial magazine Forbes has released the latest global billionaire list, with Zhang Qiansheng, Chairman of ASE Technology Holding Co., Ltd., ranking 204th in the world with a net worth of $14.2 billion, making him the richest person in Singapore. Li Xiting, founder of Mindray, ranks 284th globally with a net worth of $11.2 billion, making him the second richest in Singapore. Huang Zhida and Huang Zhixiang of Far East Organization rank 542nd and 557th globally with net worths of $7.2 billion and $7.1 billion, respectively, becoming the third and fourth richest in Singapore. Li Xiaodong of Donghai Group ranks 595th globally with a net worth of $6.8 billion, making him the fifth richest in Singapore

Zaobao

Forbes Global Billionaires List: Zhang Qiansheng, Chairman of Taiwan's ASE Semiconductor, is the richest person in Singapore | Lianhe Zaobao

"Domestic Medical Device Leader" Listed for the Third Time: Mindray Aims for Internationalization

Mindray has launched the TE Air e5M, a wireless handheld ultrasound device, enhancing whole-body scanning with versatility and affordability. The device offers 22 types of examinations, 120 minutes of battery life, and is available through Mindray North America's online store. It aims to meet diverse clinical needs in various settings, reinforcing Mindray's commitment to accessible healthcare technology.

11:08 ET
			
			
				Mindray Introduces TE Air e5M Wireless Handheld Ultrasound to Revolutionize Whole-Body Scanning

The two giants of China's medical devices are facing off

United Imaging targets the "King of Ultrasound" with a hidden agenda

688136

So far this year, more than 80 A-share companies have submitted listing applications to the Hong Kong Stock Exchange, including SDKX and Mindray. With the listing of companies such as Seres and Joyson Electronics, the number of companies achieving "A+H" listings this year has reached 16, bringing the total to over 160

SDKX

Over 80 A-share companies have submitted applications to the Hong Kong Stock Exchange this year

Mindray(300760.SZ)